SCHEMBL14879792

SCHEMBL14879792

COC(=O)c1cccc(N2CC(C)(O)C(O)C2=O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.53
OPRM1 P35372 1/20 0.47
OPRL1 P41146 1/20 0.47
GRM2 Q14416 1/20 0.46
ALDH1A1 P00352 6/20 0.46
LMNA P02545 1/20 0.46
MAPK1 P28482 1/20 0.46
TP53 P04637 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ATM Q13315 1/20 0.43
HPGD P15428 4/20 0.43
PMM2 O15305 1/20 0.43
MPI P34949 1/20 0.43
RAB9A P51151 1/20 0.43
PHOSPHO1 Q8TCT1 1/20 0.43
CTSG P08311 1/20 0.42
CMA1 P23946 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14898279 1.00 GAA (0.53) GAAOPRM1OPRL1GRM2ALDH1A1
SCHEMBL14898094 1.00 GAA (0.53) GAAOPRM1OPRL1GRM2ALDH1A1
SCHEMBL14898095 0.86 ALDH1A1 (0.50) GAAALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL15985282 0.86 LMNA (0.49) ALDH1A1LMNASMN1; SMN2ATMHPGD
SCHEMBL15861575 0.86 ALDH1A1 (0.50) GAAALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL14898096 0.86 ALDH1A1 (0.50) GAAALDH1A1SMN1; SMN2HPGDRAB9A
SCHEMBL14756890 0.86 PARP1 (0.46) GAAOPRM1OPRL1ALDH1A1LMNA
SCHEMBL15981527 0.83 SMN1; SMN2 (0.37) GAAOPRM1OPRL1ALDH1A1LMNA
SCHEMBL4121023 0.77 GAA (0.57) GAAOPRM1OPRL1GRM2ALDH1A1
SCHEMBL6568249 0.76 GAA (0.56) GAAOPRM1OPRL1GRM2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11970448-B2 Monomers capable of dimerizing in an aqueous solution, and methods of using same CORNELL UNIVERSITY (US) 2024-04-30 US disclosed
US-20200354319-A1 MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME UNIV CORNELL (US) 2020-11-12 US disclosed
US-20140194383-A1 MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME CORNELL UNIVERSITY (US) 2014-07-10 US disclosed
EP-2694707-A1 MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME Cornell University (US) 2014-02-12 EP disclosed
WO-2013058824-A1 MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME CORNELL UNIVERSITY (US) 2013-04-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11970448-B2 Monomers capable of dimerizing in an aqueous solution, and methods of using same CALCOCO2, MDN1, MBNL1 GAA 4698/4885OPRM1 1606/4885OPRL1 3201/4885
US-20200354319-A1 MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME CALCOCO2, MDN1, MBNL1 GAA 4698/4885OPRM1 1606/4885OPRL1 3201/4885
US-20140194383-A1 MONOMERS CAPABLE OF DIMERIZING IN AN AQUEOUS SOLUTION, AND METHODS OF USING SAME CALCOCO2, MDN1, MBNL1 GAA 4698/4885OPRM1 1606/4885OPRL1 3201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.